APOE-ε4 is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD) and has been linked to immune dysregulation, yet its impact on adaptive immunity remains poorly defined. We profiled adaptive immune changes in human APOE-ε3 and APOE-ε4 knock-in (KI) mice using mass cytometry (CyTOF). To assess brain...
Sem Halters, J. H. Wildeman, H. van der Stok et al.· Molecular Neurodegeneration...· 0 citations
The blood–brain barrier (BBB) protects the central nervous system by restricting entry of harmful blood-borne factors, but this selectivity actively limits delivery of therapeutics to the brain. Because BBB function is shaped by dynamic interactions within the neurovascular unit (NVU), particularly between brain endoth...
Henrique Nogueira Pinto, Lois Kistemaker, Mikhail Ponomarenko et al.· Lab on a Chip· 0 citations
In vivo FLAP antagonism ameliorates disease severity and spinal cord inflammatory gene expression in the experimental autoimmune encephalomyelitis model, an animal model of MS, in both a prophylactic and therapeutic settings.
J. Konings, Fleur Mingneau, Serhii Chornyi et al.· Acta Neuropathologica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.